The latest brain, head and neck cancer news
FDA approves selpercatinib for RET fusion-positive thyroid cancer
On June 12, 2024, the Food and Drug Administration granted traditional approval to selpercatinib (Retevmo,…
Browsing: Neuro-oncology, Head and Neck Cancers
ASCO 2024: Drug targeting protein involved in control of immune response produces encouraging results in glioblastoma
A drug that targets a protein involved in regulating the immune response might be promising…
ASCO 2024: Risk reduction from HPV vaccination goes beyond cervical cancer
Results from a new study suggest that the human papillomavirus (HPV) vaccine is effective in…
New research platform assesses brain cancer mutations during surgery
Brain cancer is difficult to treat when it starts growing, and a prevalent type, known…
Scientists uncover promising treatment target for resistant glioblastoma
For many patients with a deadly type of brain cancer called glioblastoma, chemotherapy resistance is…
Gliomas: Pairing personalised dendritic cell vaccines with poly-ICLC
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center, USA, have pinpointed a combination immunotherapy…
New mRNA cancer vaccine triggers fierce immune response to malignant brain tumour
In a first-ever human clinical trial of four adult patients, an mRNA cancer vaccine developed…
Researchers discover urine-based test to detect head and neck cancer
Researchers from the University of Michigan Health Rogel Cancer Center, USA, have created a urine-based…
Two promising ANZCHOG-sponsored clinical trials awarded funding by Australian Government
The Australian Government has awarded the Australian and New Zealand Children’s Haematology Oncology Group (ANZCHOG)…
Gene therapy is halting cancer. Can it work against brain tumours?
Grant of up to $11 million will fund a clinical trial at University of California…